Illumisoft Appoints Bill Weber as Chief Strategy Officer
News related to:Illumisoft Lighting Corp · 2 min read
Illumisoft Lighting Corp., a photonic disinfection and lighting technology company, has appointed Bill Weber as Chief Strategy Officer, effective October 7, 2026. Weber will work closely with Chief Executive Officer Ehsan Agahi and the leadership team to advance the commercialization of the company’s SaniLume upper-room germicidal UV platform and the development of its SaniLux 216 nm far-UVC technology.
Weber brings a wealth of experience to the role. He is the founder of StrategyScout and previously served as Director of New Growth Ventures in 3M Company's CTO organization, where he identified, evaluated, and developed new technology-driven growth opportunities. Earlier in his career, Weber served as General Counsel of publicly traded Cbeyond Communications, where he managed state and federal regulatory strategy and strategic transactions.
In addition to the strategic appointment, the company's board of directors has approved the grant of 500,000 stock options to Weber at an exercise price of $1.12 per common share. These options will vest in equal installments over 24 months and expire three years from the date of grant. This move underscores the company's commitment to aligning the interests of its executives with those of its shareholders.
Graham Ballachey, who previously served as President of the company, has resigned and will continue to support Illumisoft in an advisory capacity. The company thanks Ballachey for his service as President and looks forward to his continued contributions as an advisor.
Illumisoft Lighting Corp. designs, develops, and commercializes advanced ultraviolet germicidal solutions for healthcare, commercial, transportation, hospitality, and other built environments. Its portfolio includes SaniLume, an upper-room germicidal UV platform, and SaniLux, a 216 nm far-UVC platform in development.
The company has also announced that it will grant 500,000 stock options to Weber at an exercise price of $1.12 per common share. These options will vest in equal installments over 24 months and expire three years from the date of grant. The grant is subject to the approval of the TSX Venture Exchange.
Weber's appointment comes at a critical time for Illumisoft, as the company continues to advance its technology and expand its market presence. The SaniLume platform is already in use in various settings, and the SaniLux technology is in development, promising to offer new solutions in the fight against germs and pathogens.
The company's board of directors has also approved the grant of 500,000 stock options to Weber, further aligning his interests with those of the company's shareholders. The options will vest in equal installments over 24 months and expire three years from the date of grant. This move demonstrates the company's commitment to fostering a strong and aligned executive team.
Graham Ballachey, who has served as President of the company, has resigned and will continue to support Illumisoft in an advisory capacity. The company expresses its gratitude to Ballachey for his service and looks forward to his continued contributions as an advisor.
Illumisoft Lighting Corp. is dedicated to providing innovative solutions for disinfection and lighting in various environments. With the appointment of Weber and the ongoing development of its technologies, the company is well-positioned to continue its growth and impact in the industry.